- Home
- Articles
- latamerica
- cancer tissue
Refine by
Cancer Tissue Articles & Analysis
55 articles found
ENPP2 in Disease: Insights from Cancer, Fibrosis, and Neurobiology Pathological dysregulation of ENPP2 is associated with multiple diseases. ...
Adenocarcinoma of the breast represents a significant subset of breast cancers, characterized by the malignancy of glandular tissues. This specific article focuses on the right medial segment, highlighting its histopathological features, diagnostic methods, and potential therapeutic avenues. ...
Alfa Cytology has revealed new FAP-targeted therapeutics development services that aim to develop precise and effective cancer treatments. Alfa Cytology has introduced its groundbreaking initiative which targets fibroblast activation protein(FAP) for cancer therapies. ...
Researchers are increasingly focused on engineering antibodies that can selectively target specific cancer cells or diseased tissues while minimizing off-target effects. ...
These innovative therapeutic agents combine the targeting capabilities of antibodies with the cytotoxic effects of radioactive isotopes, providing a powerful strategy for precision cancer treatment. Understanding Radioactive Drug Conjugates Radioactive drug conjugates are engineered to deliver radiation directly to cancer cells while sparing healthy ...
Antibody-Drug Conjugates (ADCs) represent a groundbreaking advancement in targeted cancer therapy, combining the specificity of antibodies with the potency of cytotoxic drugs. ...
Alfa Cytology has launched ovarian cancer therapy development services. Alfa Cytology, a prominent services provider in oncology, has launched its cutting-edge ovarian cancer therapy development services. ...
Alfa Cytology unveils advanced cancer immunotherapy development services. Alfa Cytology, a renowned services supplier in oncology, has recently introduced its groundbreaking cancer immunotherapy development services. ...
This precision targeting is critical for treating diseases such as cancer, where minimizing damage to healthy tissues while aggressively targeting cancerous cells is paramount. ...
The NP recognition by the immune system and NPs synthesis by the reticuloendothelial system are the primary barriers to nano drug delivery to organs, tissues and lesions. Also, NPs have a negative side effect, like microcirculatory embolism. ...
This cutting-edge initiative represents a major advancement in creating more precise and versatile cancer treatment paradigms. As the landscape of cancer treatment continues to evolve, there is a growing need for innovative and personalized therapeutic approaches. Conventional therapies often fall short in their ability to selectively target ...
Bladder cancer, characterized by the uncontrolled proliferation of abnormal cells within the bladder lining, poses significant treatment challenges due to its potential to invade surrounding tissues and surrounding propensity for recurrence. ...
Breast cancer remains one of the most prevalent malignancies affecting women worldwide, necessitating innovative approaches for effective treatment and research. ...
Precision-Cut Lung Slices (PCLS) have emerged as a innovative ex vivo model that allows researchers to explore deep into lung physiology, disease mechanisms, and pharmacological responses. By offering a unique combination of biological complexity and controlled experimental conditions, PCLS serve as a critical bridge between the limitations of traditional in vitro cell cultures and the ...
An article on the identification of phospholipids relevant to cancer tissue using DMS has been published in the International Journal of Molecular Sciences! Identification of three cancer-relevant phospholipids, phosphatidylcholine (PC), phosphatidylinositol (PI), and phosphatidylethanolamine (PE) was studied. ...
This synergistic approach allows for targeted delivery of the cytotoxic agent to cancer cells while sparing healthy tissues, thereby reducing side effects and enhancing therapeutic efficacy. ...
At present, peptide drugs have shown broad application prospects in the treatment of tumors, hepatitis, diabetes, and AIDS.Antibody-Based TherapyAntibodies are proteins produced by the immune system that can bind to specific markers on cells or tissues. In cancer treatment, monoclonal antibodies (mAbs) can directly kill cancer cells, prevent the ...
Breast cancer is a type of cancer that begins in the cells of the breast. It can occur in both men and women but is more common in women. ...
Nanoparticles can be engineered to target specific cells or tissues, such as cancer cells, minimizing the impact on healthy cells and reducing side effects. ...
In the past few years, Raman has been used in dental and cancer studies, and is now building on this success by extension into Point-of-Care (POC) applications. This article gives an overview of some very new and exciting research into the use of Raman spectroscopy for the detection of cancerous tissue, biomarkers of disease, and pathogens that ...
ByB&W Tek